Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Postoperative Recovery in OSA
NCT03109418Phase 3Terminated
- Sponsor
- University of Alabama at Birmingham
- Start
- Jun 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketamine in postoperative pain (2 arms), sponsored by University of Alabama at Birmingham. Primary endpoint: Pain Scores at 24 hours. Started Jun 2016; status: terminated.
02
Drugs
ketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03109418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03109418.